172 related articles for article (PubMed ID: 7958907)
1. Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma.
Glick AB; Lee MM; Darwiche N; Kulkarni AB; Karlsson S; Yuspa SH
Genes Dev; 1994 Oct; 8(20):2429-40. PubMed ID: 7958907
[TBL] [Abstract][Full Text] [Related]
2. p53 gene dosage modifies growth and malignant progression of keratinocytes expressing the v-rasHa oncogene.
Weinberg WC; Azzoli CG; Kadiwar N; Yuspa SH
Cancer Res; 1994 Nov; 54(21):5584-92. PubMed ID: 7923201
[TBL] [Abstract][Full Text] [Related]
3. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
[TBL] [Abstract][Full Text] [Related]
4. Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion.
Glick AB; Kulkarni AB; Tennenbaum T; Hennings H; Flanders KC; O'Reilly M; Sporn MB; Karlsson S; Yuspa SH
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6076-80. PubMed ID: 7687059
[TBL] [Abstract][Full Text] [Related]
5. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
Dlugosz AA; Cheng C; Williams EK; Darwiche N; Dempsey PJ; Mann B; Dunn AR; Coffey RJ; Yuspa SH
Cancer Res; 1995 May; 55(9):1883-93. PubMed ID: 7728756
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta 1 and skin carcinogenesis: antiproliferative effect in vitro and TGF-beta 1 mRNA expression during epidermal hyperproliferation and multistage tumorigenesis.
Krieg P; Schnapke R; Fürstenberger G; Vogt I; Marks F
Mol Carcinog; 1991; 4(2):129-37. PubMed ID: 1710462
[TBL] [Abstract][Full Text] [Related]
7. Targeted disruption of the epidermal growth factor receptor inhibits development of papillomas and carcinomas from human papillomavirus-immortalized keratinocytes.
Woodworth CD; Gaiotti D; Michael E; Hansen L; Nees M
Cancer Res; 2000 Aug; 60(16):4397-402. PubMed ID: 10969784
[TBL] [Abstract][Full Text] [Related]
8. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
[TBL] [Abstract][Full Text] [Related]
9. Role of oncogenes and tumor suppressor genes in multistage carcinogenesis.
Yuspa SH; Długosz AA; Cheng CK; Denning MF; Tennenbaum T; Glick AB; Weinberg WC
J Invest Dermatol; 1994 Nov; 103(5 Suppl):90S-95S. PubMed ID: 7963691
[TBL] [Abstract][Full Text] [Related]
10. Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis.
Weinberg WC; Montano NE; Deng C
Oncogene; 1997 Aug; 15(6):685-90. PubMed ID: 9264409
[TBL] [Abstract][Full Text] [Related]
11. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras.
Tremain R; Marko M; Kinnimulki V; Ueno H; Bottinger E; Glick A
Oncogene; 2000 Mar; 19(13):1698-709. PubMed ID: 10763827
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
[TBL] [Abstract][Full Text] [Related]
13. Altered regulation of TGF-beta 1 and TGF-alpha in primary keratinocytes and papillomas expressing v-Ha-ras.
Glick AB; Sporn MB; Yuspa SH
Mol Carcinog; 1991; 4(3):210-9. PubMed ID: 2064727
[TBL] [Abstract][Full Text] [Related]
14. Multistage carcinogenesis in the skin.
Yuspa SH; Dlugosz AA; Denning MF; Glick AB
J Investig Dermatol Symp Proc; 1996 Apr; 1(2):147-50. PubMed ID: 9627709
[TBL] [Abstract][Full Text] [Related]
15. Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model.
Vijayachandra K; Lee J; Glick AB
Cancer Res; 2003 Jul; 63(13):3447-52. PubMed ID: 12839923
[TBL] [Abstract][Full Text] [Related]
16. Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis.
Hennings H; Glick AB; Greenhalgh DA; Morgan DL; Strickland JE; Tennenbaum T; Yuspa SH
Proc Soc Exp Biol Med; 1993 Jan; 202(1):1-8. PubMed ID: 8424089
[TBL] [Abstract][Full Text] [Related]
17. Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma.
Greenhalgh DA; Welty DJ; Player A; Yuspa SH
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):643-7. PubMed ID: 2153961
[TBL] [Abstract][Full Text] [Related]
18. The transcriptional regulatory function of p53 is essential for suppression of mouse skin carcinogenesis and can be dissociated from effects on TGF-beta-mediated growth regulation.
Ponnamperuma RM; King KE; Elsir T; Glick AB; Wahl GM; Nister M; Weinberg WC
J Pathol; 2009 Oct; 219(2):263-74. PubMed ID: 19718706
[TBL] [Abstract][Full Text] [Related]
19. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.
Han G; Lu SL; Li AG; He W; Corless CL; Kulesz-Martin M; Wang XJ
J Clin Invest; 2005 Jul; 115(7):1714-23. PubMed ID: 15937546
[TBL] [Abstract][Full Text] [Related]
20. Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development.
Amendt C; Schirmacher P; Weber H; Blessing M
Oncogene; 1998 Jul; 17(1):25-34. PubMed ID: 9671311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
